Cilostazol 50 MG

DRUG2 trials

Sponsors

Sadat City University

Conditions

Fatty Liver, NonalcoholicOsteoarthritis

Phase 1

Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease

WithdrawnNCT04761848

Sadat City UniversityFatty Liver, Nonalcoholic

Start: 2021-02-16End: 2024-12-31Updated: 2025-07-14

The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis

WithdrawnNCT04789837

Sadat City UniversityOsteoarthritis

Start: 2021-03-01End: 2024-12-31Updated: 2025-07-14